healthneutral
Millions of People Taking a Popular Antidepressant Face a Recall Due to Cancer-Causing Chemical
Tuesday, December 10, 2024
Duloxetine is part of a group of medicines called SSNRIs. These medicines boost brain chemicals like serotonin and norepinephrine. More than 23 million Americans take duloxetine each year to treat depression and anxiety.
This isn't the first recall for duloxetine. In October, another batch sold as Cymbalta was recalled. No illnesses have been reported, but long-term exposure to nitrosamines can increase cancer risks.
The FDA is investigating how nitrosamines get into drugs. They could come from the manufacturing process, storage conditions, or even how the body processes them. If you're taking a medication with potential nitrosamine impurities, chat with your doctor first before stopping.
Actions
flag content